AN2 Therapeutics
ANTX
#9107
Rank
NZ$0.23 B
Marketcap
NZ$6.42
Share price
4.97%
Change (1 day)
206.16%
Change (1 year)

Earnings for AN2 Therapeutics (ANTX)

Earnings in 2025 (TTM): -NZ$64.78 Million

According to AN2 Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$92.18 Million, an increase over its 2023 earnings that were of -NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AN2 Therapeutics from 2021 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$64.78 Million-29.73%
2024 -NZ$92.18 Million-21.66%
2023 -NZ$0.12 Billion64.77%
2022 -NZ$71.41 Million95.89%
2021 -NZ$36.46 Million